NCT06784726 2026-03-13Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-TUniversity of WashingtonPhase 2 Recruiting27 enrolled
NCT07098364 2026-01-14ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell LymphomaFred Hutchinson Cancer CenterPhase 1/2 Recruiting33 enrolled